Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis

PURPOSE: Comparison of efficacy and safety of 0.2% and 0.18% hyaluronic acid (HA) eye drops three times a day (tid) in patients with moderate to severe dry eye disease, related to keratitis or keratoconjunctivitis. PATIENTS AND METHODS: Prospective, multicenter, randomized, single-masked, phase IIIb...

Descripción completa

Detalles Bibliográficos
Autores principales: Groß, Dorothea, Childs, Marc, Piaton, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388258/
https://www.ncbi.nlm.nih.gov/pubmed/28435213
http://dx.doi.org/10.2147/OPTH.S131384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388258/
https://www.ncbi.nlm.nih.gov/pubmed/28435213
http://dx.doi.org/10.2147/OPTH.S131384

Ejemplares similares